IMPEDIMED LIMITED ORDINARY (IPD) Short Interest
IMPEDIMED LIMITED ORDINARY (ASX:IPD) had 0.00% of shares reported as short positions as of 16 July 2026, representing 99,795 shares. IMPEDIMED LIMITED ORDINARY operates in the Health Care Equipment & Services industry. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
Impedimed
Impedimed is a global leader in medical technology, specializing in the development and sale of devices using bioimpedance spectroscopy for noninvasive clinical assessment. The company focuses on addressing the challenges of secondary lymphedema, particularly related to breast cancer, through innovative solutions like the SOZO® Digital Health Platform. With operations in the US, Europe, and Australia, Impedimed is committed to improving patient outcomes by setting new standards of care.
Short position
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4IPD intelligence dossier
Public-source evidence for this company, with industry drill-up links.
- Tax paid and taxable income records
- Government contracts and public money
- Emissions and trade exposure
- Political donations and lobbying links
Short interest history & FAQ
Company
AI-generated research profile of Impedimed
About
More Health Care Equipment & Services Stocks
Other shorted stocks in this sector
Be the first to discuss IPD
Start a research thread or post the first pulse update